Amy E. McKee - 20 Sep 2021 Form 4 Insider Report for BIOCRYST PHARMACEUTICALS INC (BCRX)

Role
Director
Signature
/s/ Jessica Dickerson, by power of attorney
Issuer symbol
BCRX
Transactions as of
20 Sep 2021
Net transactions value
$0
Form type
4
Filing time
22 Sep 2021, 16:15:41 UTC
Next filing
09 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCRX Non-Qualified Stock Option Award $0 +53,333 $0.000000 53,333 20 Sep 2021 Common Stock 53,333 $15.02 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Amended and Restated Stock Incentive Plan.
F2 The option vests 1/36 per month for a period of 36 months, beginning on October 20, 2021